FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

New Vitalis Pharmacy LLC dba New Vitalis Pharmacy Testosterone Cypionate 180 Recall

Testosterone Cypionate 180 mg/mL/Testosterone Propionate 20mg/mL Oil Injection Solution…

New Vitalis Pharmacy LLC dba New Vitalis Pharmacy · Louisville, KY

Risk level
Class II
Reported by FDA
Dec 4, 2019
Recall ID
D-0523-2020
Check your lot numberHow we source this data

Summary

New Vitalis Pharmacy LLC dba New Vitalis Pharmacy recalled Testosterone Cypionate 180 starting Oct 1, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0523-2020 on Dec 4, 2019. Reason: Lack of sterility assurance. Status: Terminated.

Why it was recalled

Lack of sterility assurance.

Product description

Testosterone Cypionate 180 mg/mL/Testosterone Propionate 20mg/mL Oil Injection Solution, 10 mL per vial, New Vitalis Pharmacy

Lot numbers, UPCs & expiration codes

Lot, expiry: AL-07232019@99, exp 9-23-2019; AL-07312019@99, exp 9-30-2019; AL-08132019@99, exp 10-13-2019; AL-08272019@901, exp 10-27-2019; AL-08282019@909, exp 10-28-2019; Al-09032019@903, exp 11-3-2019

Where it was sold

Distributed Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0523-2020
Classification
Class II
Status
Terminated
Recall initiated
Oct 1, 2019
FDA report date
Dec 4, 2019
Quantity
2981.62 mL
Recall type
Voluntary: Firm initiated
Recalling firm
New Vitalis Pharmacy LLC dba New Vitalis Pharmacy

Original FDA data

Every field from FDA enforcement report D-0523-2020, exactly as published.

Show all FDA fields
City
Louisville
State
KY
Status
Terminated
Country
United States
Event ID
84189
Address
4139 Cadillac Ct Ste 201
Code information
Lot, expiry: AL-07232019@99, exp 9-23-2019; AL-07312019@99, exp 9-30-2019; AL-08132019@99, exp 10-13-2019; AL-08272019@901, exp 10-27-2019; AL-08282019@909, exp 10-28-2019; Al-09032019@903, exp 11-3-2019
Postal code
40213-1578
Report date
Dec 4, 2019
Product type
Drugs
Recall number
D-0523-2020
Classification
Class II
Recalling firm
New Vitalis Pharmacy LLC dba New Vitalis Pharmacy
Product quantity
2981.62 mL
Termination date
Mar 9, 2023
Reason for recall
Lack of sterility assurance.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Testosterone Cypionate 180 mg/mL/Testosterone Propionate 20mg/mL Oil Injection Solution, 10 mL per vial, New Vitalis Pharmacy
Distribution pattern
Distributed Nationwide in the USA
Recall initiation date
Oct 1, 2019
Initial firm notification
Letter
Center classification date
Nov 25, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0523-2020, published Dec 4, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls